SARS-CoV-2 IgG Antibody Test Kit (Fluorescence immunochromatography)
Let the assistant research this device
The Research Assistant compiles risk class, certificates, notified bodies and related records — and cites every one.
Free to try · every answer cites its records
Basic Information
- Primary DI
- 06970877682019
- Basic UDI-DI Code
- B-06970877682019
- Reference
- 0201
- Device Types
-
Single use
- Regulation
- Eu Ivdd
- Classification
- Eu Ivd General
- Status
- On The Market
- Manufacturer
- Kangmei Tianhong Biotech (Beijing) Co., Ltd.
Additional Description
This kit is used for quantitative determination of IgG antibody content of new coronavirus (2019 nCoV) in human serum, plasma and whole blood samples in vitro. By detecting the content of IgG antibody against the new coronavirus (2019 nCoV) in the sample, it can be used as an auxiliary means to judge whether there is virus infection experience in the body and the immune response ability of the body to the new coronavirus (2019 nCoV) after virus infection, and can be used as an auxiliary basis to determine the vaccine injection demand.
CND Nomenclature Codes
| Code | Description |
|---|---|
| W01021699 | RAPID TESTS & POINT OF CARE - IMMUNOCHEMISTRY - OTHER |
Similar Devices
Other on-the-market devices with the same classification (Eu Ivd General) and regulation (EU IVDD).